Trade Summary

2 days ago, Goncalves Joana, serving as Chief Medical Officer at Oruka Therapeutics, Inc. (ORKA), sold 7,641 shares at $40.91 per share, for a total transaction value of $312,560.00. Following this transaction, Goncalves Joana now holds 33,377 shares of ORKA.

This sale represents a 19.00% decrease in Goncalves Joana's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 16, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, March 17, 2026, 1 day after the trade was made.

Oruka Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.